IMPLEMENTING THE HCH FOR PATIENTS WITH AD: EARLY IDENTIFICATION, CARE COORDINATION & CAREGIVER SUPPORT Health Care Homes Learning Day, November 1, 2012.

Slides:



Advertisements
Similar presentations
 Most common and important degenerative disease of the brain  Shrinkage in size and weight of the brain  Severe degree of diffuse cerebral atrophy.
Advertisements

APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
The Three Ds of Confusion Delirium, Depression, Dementia
Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
Frontotemporal Dementia
Martha Stearn, MD Institute for Cognitive Health St John’s Medical Center Jackson, Wyoming.
Brief Cognitive Assessment Tool (BCAT®) Training Program
Dementia & Delirium in Surgical Patients Damian Harding Department of Geriatric Medicine February 2008.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
The New Brief Cognitive Assessment Tool (BCAT): The Role of Cognitive Assessment in Improving Health Outcomes Dr. William Mansbach October 25, 2011.
ACT on Alzheimer’s Disease Curriculum Module VI: Screening.
University of Kansas Medical Center
ACT on Alzheimer’s Disease Curriculum Module VII: Disease Diagnosis.
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
The National Task Group Early Detection Screen for Dementia
Recognition of Dementia Syed Zaman Consultant Physician Geriatric Medicine Palmerston North Hospital.
Indianapolis Discovery Network for Dementia Translating PREVENT Into Your Practice Caring for your patients with dementia J. Eugene Lammers, MD, MPH Clarian.
+ Module Four: Patient/Family Education and Self-Management At the end of this module, the participant will be able to: Describe three learning needs of.
Primary Care Psychology Lisa K. Kearney, Ph.D. Primary Care Psychologist South Texas Veterans Health Care System.
Alzheimer’s Association of Northern CA & NV 251 Lafayette Circle, Suite 250 Lafayette, CA
Wyoming Total Population Health Management and Utilization Management Program Overview May 28, 2015.
ALZHEIMER’S DISEASE BY JOSEPH MOLLUSO.
Chapter 16: Cognitive Disorders: Delirium, Dementia, and Amnestic Disorders Copyright © 2012, 2007 Mosby, Inc., an affiliate of Elsevier Inc. All rights.
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Copyright © 2007, 2003 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 37 Confusion and Dementia.
DEMENTIA AND ALZHEIMER'S DISEASE. IMPAIRMENT OF BRAIN FUNCTION ( DECLINE IN INTELLECTUAL FUNCTIONING) THAT INTERFERES WITH ROUTINE DAILY ACTIVITIES. MENTAL.
Geriatric Psychiatry Services JoAnn Pelletier-Bressette, RN, Nurse Manager Nancy Hooper, BScN, RN, CPMHN (C) 1.
ACT on Alzheimer’s Disease Curriculum Module V: Cognitive Assessment and the Value of Early Identification.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 33 Delirium and Dementia.
Laurence Lacoste Ph. D, Paris, France 1*. Introduction : Why ?  Population’s Ageing is a Public Health issue and dementia for the Elderly a reality 
1 From Cause to Movement Shaping a World Without Alzheimer’s Through Advocacy, Volunteerism, Referral and Science Ian Kremer, Esq. Advocacy & Outreach.
CONFUSION & DEMENTIA CHAPTER 35.
Copyright 2008 CareTrust Publications Illegal to copy without a license from the publisher. Understanding Alzheimer’s Disease - Is Dementia or Forgetfulness?
Cognitive Disorders Chapter 15. Defined as when a human being can no longer understand facts or connect the appropriate feelings to events, they have.
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
What are the warning signs? How can I help?.  Aging & Disability Resource Center ◦  Alzheimer’s & Dementia Alliance of.
Non Alzheimer's Dementias Elizabeth Landsverk, MD Geriatrician, ElderConsult Geriatric Medicine Adjunct Professor of Medicine, Stanford University.
Understanding Mild Cognitive Impairment. Objectives Understand the concept of MCI Identify risk factors for progression to dementia Review clinical trial.
Chapter 39 Confusion and Dementia All items and derived items © 2015, 2011 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
Mosby items and derived items © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 44 Confusion and Dementia.
Module 3: Alzheimer’s Disease – What is the Role of Public Health? A Public Health Approach to Alzheimer’s and Other Dementias.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
The Alzheimer’s Disease Challenge: Take Your Knowledge Further ALZHEIMER’S DISEASE AND ITS MANAGEMENT: AN OVERVIEW.
Identifying and Tracking Changes in Cognition Related to NPH Sheldon Herring, Ph.D. Clinical Director Outpatient Brain Injury and Young Stroke Program.
Dementia: Early Assessment Early Diagnosis Early Treatment Janice Knoefel, MD MPH Geriatrics, Internal Medicine, Neurology University of New Mexico.
Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 1 Chapter 17 Cognitive Impairment, Alzheimer’s Disease, and Dementia.
Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.
An Introduction to Home Health Care in the United States: Role of the Physician and Benefits of Home Health Care Tracy Gutman, MD Geriatrics Fellow University.
1 Cognitive Impairment and Dementia: What You Need to Know about Alzheimer's Disease and Related Disorders Part 2 – Clinical focus Susan Rowlett, LICSW.
Dementia Made Easier: Tools for working with physicians & clinics Terry R Barclay, PhD Director, HealthPartners Neuropsychology.
Orientation to Early Memory Loss. Let’s look for some answers… What is happening? What should I do? Where should I go?
COGNITIVE DEVELOPMENT IN LATE ADULTHOOD CHAPTER 18 Lecture Prepared by: Dr. M. Sawhney.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
Comprehensive geriatric assessment (CGA)
Memory and Aging Educational Presentation Presented by Tessa Lundquist, M.S. University of Massachusetts Amherst.
Chapter 10: Nursing Management of Dementia
Dementia Dr.Mansour K. Alzahrani.  Define the dementia  Discuss the prevalence of dementia  Discuss the impact of dementia on the individual and the.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
Dementia: Clerkship talk
The Malfunctioning Mind: Degenerative Diseases of the Brain
Dementia Jaqueline Raetz, M.D..
Dementia Jaqueline Raetz, M.D..
What is Dementia? A term that describes a wide range of symptoms associated with a decline in memory or other thinking skills. Dementia may be severe.
Chapter 30 Delirium and Dementia
Geriatric Psychiatry Community Services of Ottawa Services communautaires de géronto-psychiatrie d’Ottawa G P S O C Vickie Demers Clinical Coordinator.
The Memory Assessment and Treatment Service (MATS)
Risk Factors and Therapies for Vascular Dementia:
Presentation transcript:

IMPLEMENTING THE HCH FOR PATIENTS WITH AD: EARLY IDENTIFICATION, CARE COORDINATION & CAREGIVER SUPPORT Health Care Homes Learning Day, November 1,

Session Overview  Introduction to Health Care Home (HCH)  Overview  Successful HCH: physician & care coordinator perspectives  Alzheimer’s Disease and HCH  Overview  AD in HCH: physician & care coordination roles  Alzheimer’s Disease: Firsthand experience  Conclusion / Q&A

Successful HCH  Dr. Johnson presentation  Panel discussion

AD Overview 4

Facts & Figures& Figures Alzheimer’s Association 2011

Today, Alzheimer’s Disease Is:  Fatal  Prevalent  Expensive  Misunderstood  Stigmatized  Under-diagnosed  Under-treated  ON THE RISE….

Alzheimer’s Epidemic  By 2050:  13 million to 16 million Americans will have AD  Consume 1.1 trillion in healthcare spending

Today  Fewer than 50% of patients receive formal diagnosis Diagnosis often delayed by 6+ Years Impairment in function by time it is recognized  Fewer than 50% of those diagnosed receive any treatment

Why is Early Diagnosis Important? 1. Optimize current medical management 2. Relief gained from better understanding 3. Maximize decision-making autonomy 4. Access to services 5. Risk reduction 6. Plan for the future* 7. Improve clinical outcomes* 8. Avoid or reduce future costs 9. Diagnosis as a human right World Alzheimer Report 2011 *Top benefits endorsed by physicians, International Alzheimer’s Disease Physician Survey, 2012

Alzheimer’s Disease: Course, Prevention, Treatment Strategies 10 INTERVENTION Primary Prevention Secondary Prevention Treatment CLINICAL STATE Normal Pre- symptomatic AD Mild Cognitive Impairment AD Numbers of people ??? 20 to 60 mil 10 to 15 mil 5.3mil BRAIN PATHOLOGIC STATE No disease No symptoms Early AD brain changes No symptoms AD brain changes Mild symptoms Mild, moderate or severe impairment STRATEGIES Identify at-risk Prevent AD Prevent or delay emergence of symptoms Stimulate memory Slow progression Treat cognition Treat behaviors Slow progression DISEASE PROGRESSION

AD: Physician Perspective 11

Alzheimer’s, the Scope of the Problem  Most significant Risk Factor  Age  Prevalence of Cognitive Impairment  50% of those >85  Co-morbidities  At least one present in 95%

Easy Practice Tips

Practice Tips  Red flags  Repetition (not normal in 7-10 min conversation)  Tangential, circumstantial responses  Losing track of conversation  Frequently deferring to family  Over reliance on old information/memories  Inattentive to appearance  Unexplained weight loss or “failure to thrive”

Practice Tips  Family observations:  ANY instances whatsoever of getting lost while driving, trouble following a recipe, asking same question repeatedly, mistakes paying bills  Ask:  “Let’s suppose your family member was alone on a domestic flight across the country and the trip required a layover with a gate change. Would he/she be able to manage that kind of mental task on his/her own?”

Practice Tips  Intact older adult should be able to:  Describe 2 current events in some detail  Describe what happened on 9/11, New Orleans disaster  Name the current President and 2 immediate predecessors  Describe medical history and names of some medications

Dementia Care  Screening  Diagnosis  Management

Rationale for Early Detection 1. Improve quality of life  Early treatment is more effective  Stabilization vs. improvement  Patients can make decisions regarding care  Patients can get to their “bucket list”  Decrease burden on family and caregivers 2. Connection to services that promote independent (supported) living as long as possible  RTC support/counseling intervention (Mittelman et al. Neurology 2006)  Non-pharm interventions reduce NH placement by 30% and delay placement for others by 18+ months

Rationale for Early Detection 3. May find reversible causes  NPH, TSH, B12, hypoglycemia, depression 4. Improve management of co-morbid conditions  Underlying dementia = a primary risk factor of poor compliance in the elderly  Chronic disease (diabetes, hypertension, anticoagulation)  Integrity of the brain related to one’s ability to manage health  Dementia as the Organizing Principle of Care

Rationale for Early Detection 5. Reduce ineffective and expensive crisis-driven use of healthcare resources  Unhelpful emergency room visits and hospitalizations  Prevent diagnosis during crises (wandering, hospitalization, car accidents, bankruptcy) 6. More time to participate in clinical trials and important scientific studies  Knowledge gap re: earlier stages  Find a cure

Screening  Initial considerations  Balance b/w time and sensitivity/specificity  How will your practice incorporate screening?  Who will administer tests? MDs, Nurses, social workers, allied health professionals  What happens when screen is positive?

Annual Wellness Visit: Medicare  Took effect January 1, 2011  Affordable Care Act  Medicare will cover an annual wellness visit which will include the creation of a personalized prevention plan  For first time, “detection of cognitive impairment” is core feature of the exam  Diagnosis of dementia requires a decline in function over time, so screen provides a baseline on cognition

Screening Measures  Wide range of options  Mini-Cog (MC)  Mini-Mental State Exam (MMSE)  St. Louis University Mental Status Exam (SLUMS)  Montreal Cognitive Assessment (MoCA)  All but MMSE free online in public domain  Utilize “Family Questionnaire (if family available)

Mini-Cog Contents Verbal Recall (3 points) Clock Draw (2 points) Advantages Quick (2-3 min) Easy High yield (executive fx, memory, visuospatial) Subject asked to recall 3 words Leader, Season, Table Subject asked to draw clock, set hands to 10 past

Mini-Cog  Performance unaffected by education or language Borson Int J Geriatr Psychiatry 2000  Sensitivity and Specificity similar to MMSE (76% vs. 79%; 89% vs. 88%) Borson JAGS 2003  Does not disrupt workflow & increases rate of diagnosis in primary care Borson JGIM 2007  Failure associated with inability to fill pillbox Anderson et al Am Soc Consult Pharmacists 2008

Mini-Cog  Pros  Easy to administer  Minimal time commitment  Clock sensitive to visuospatial & executive dysfunction  Simple scoring and interpretation  Cons  Not as sensitive for MCI or early dementia when compared to longer screens  Brevity means less information to interpret

Screen Failure  MiniCog = <4  OR memory complaints by patient/family  Schedule follow-up appt Insist on family collateral Perform more complex test (MOCA, SLUMS, MMSE)

MMSE

Pass  > 26 Fail  25 or less

 Pros  Widely accepted and validated for dementia screening  30-point scale well known and score easily interpretable  Measures orientation, working memory, recall, language, praxis  Cons  Scale developed 40 years ago, before MCI criteria and when early dementia less well understood  Lacks sensitivity to MCI and early dementia  Takes 7+ min. to administer  Copyright issues MMSE

SLUMS

 Pros  More measures of executive functioning  Good balance between easy and difficult items  More sensitive than MMSE in detecting MCI and early dementia  30-point scale similar to MMSE  Score range for MCI and dementia  Free online  Cons  Takes 10 min. to administer  Slightly more complex directions than MMSE  Less name recognition than MMSE SLUMS

Pass  > 26 Fail  25 or less

MoCA

Pass  > 26 Fail  25 or less

 Pros  Much more sensitive than MMSE for MCI and early dementia  More content tapping higher level executive fx  30-point scale similar to MMSE  Translations available in 35+ languages  Free online  Cons  Takes min. to administer  More complex administration and directions than MMSE MoCA

Screening Tool Selection Montreal Cognitive Assessment (MoCA)  Sensitivity: 90% for MCI, 100% for dementia  Specificity: 87% St. Louis University Mental Status (SLUMS)  Sensitivity: 92% for MCI, 100% for dementia  Specificity: 81% Mini-Mental Status Exam (MMSE)  Sensitivity: 18% for MCI, 78% for dementia  Specificity: 100% Larner et al Int Psychogeriatr 2012; Nasreddine et al J Am Geriatr Soc 2005; Tariq et al Am J Geriatr Psychiatry 2006; Ismail et al Int J Geriatr Psychiatry 2010

Dementia Care  Screening  Diagnosis  Management

Diagnostic Workup  H&P  Diagnostics  Labs  Imaging  Neuropsychological assessment  Diagnosis  Family meeting

History & Physical  History (with collateral)  Onset, duration, course  Examples of memory difficulties  Impact on function $ management, meds, driving, cooking  Mood, personality or behavior changes  Drug or alcohol use  Medication side effects  Physical + brief neuro exam  Do depression screening (PHQ-9), if not already completed

Diagnostics: Labs  Routine Labs  CBC  Electrolytes  BUN/creatinine  Glucose  Calcium  LFTs--??  Dementia screening  Vitamin B12, folate  TSH  Contingent labs  RPR or MHA-TP  HIV  Heavy metals

Diagnostics: Imaging  CT adequate for pts with clinical history consistent with AD  MRI helpful for determining pattern of focal atrophy  Request radiologist comment on hippocampal volume  Scans often unremarkable in patients with early AD  Rule out focal lesions, trauma, ischemia, NPH  No need to repeat if pt. had recent scan  Within 12 months  No recent hx of trauma

Diagnostics: Neuropsych Testing  Helpful in distinguishing normal aging from MCI and dementia  Atypical presentations  Rule out:  Pseudodementia, substance abuse factors, etc.  Determine type of dementia, stage, capacity, most appropriate level of support  Consider particularly when: MoCA SLUMS MMSE 18-28

 Loss of Memory  Plus one of the following  Impairment in handling complex tasks (balancing a check book, calendars, clock drawing)  Impairment in reasoning ability  Impaired spatial ability and orientation (lost)  Impaired language (word finding)  Severe enough to impact daily life and is a decline from previous function Dementia Diagnosis

Diagnosis Alzheimer’s disease: % Includes mixed AD + VD Lewy Body Dementia: %  Parkinson spectrum Vascular Dementia: 6-10 %  Stroke related Frontotemporal Dementia: 2-5 %  Personality or language problems

Vascular Dementia  Clinical Features  Focal neurological signs  Stepwise progression  Often overlaps with AD (6-10% dementia related to pure VD)  Neuropsychological Testing  Predominant deficits in executive function, attention, and processing speed  Neuroimaging  Cerebrovascular Disease Large vessel stroke Periventricular/subcortical white matter disease

Dementia with Lewy Bodies  Clinical Features  Parkinsonism, hallucinations, cognitive fluctuations, REM behavioral sleep disorder  Neuropsychological Testing  Predominant visuospatial dysfunction with relative sparing of verbal memory  Neuroimaging  Non-specific MRI atrophy pattern  Occipital hypometabolism on FDG-PET

Frontotemporal Dementia  Clinical Features  Typical onset prior to age 65  Behavioral symptoms Disinhibition, apathy, loss of empathy, repetitive stereotyped movements, hyperorality  Language symptoms Expressive aphasia, anomia, surface dyslexia  Neuropsychological Testing  Impairments on executive function/language with relative sparing of episodic memory and visuospatial function  Neuroimaging  Atrophy of frontal and anterior temporal cortex

Dementia Care  Screening  Diagnosis  Management

Overall Management  Goals;  Reduce suffering that accompanies the disease  Reduce the negative impacts that dementia has on both health & quality of life  Balancing independence & safety  Optimize the management of co-morbid conditions  Weighing benefits, burdens & risks of treatments  Care Plan for acute illness  Supporting the Caregiver

Management  Medication treatment  Small component of care plan  Education  Increase family’s dementia competence  Support / Referral  Connect to community resources

AD: Care Coordination 57

Intervention Model - Clinic Patient Care Partners Care Coordinator Physician / Clinic

Care Coordination  Identify cognitive impairment, facilitate diagnosis  Identify ‘team members’, including care partner  Conduct needs assessment  Develop & initiate care plan  Communicate with team  Monitor & re-evaluate  Termination 59

Clinic Care Coordination Needs  Care partner / team approach  Disease education  Assistance with medication management  Written materials / plans  POA / healthcare directive  Appointment reminders  Driving assessment / transportation options  Occupational therapy / home safety assessment, fall risk  Risk reduction strategies  Connection to community resources & programs 60

Risk Reduction  Genetic Factors: APP, Presinilin 1 &2 / APOE4  Environmental Factors: begins in mid-life (50%)  Mid-life HTN & Obesity (60%)  Physical Inactivity (40 – 80%)  Mid-life Depression (40 – 80%)  Low Education / Cognitive Reserve (60 – 80%)  Smoking (60%)  Alcohol – Late Life & Binge Drinking (2xmo)  Sleep Hygiene : quality & quantity

62 Mild Cognitive Impairment (MCI) Current Services in Minnesota Medical Evaluation / Diagnosis / Pharmacological Treatment* Research / Clinical Trials* Care Coaching / Consultation / Counseling* Information / Education* MCI Support Groups* Engagement Programs (arts, social, creativity)* Exercise / Nutrition / Cognitive Habilitation* * limited availability

63 Early Stage Current Services in Minnesota Medical Evaluation / Diagnosis / Pharmacological Treatment* Research / Clinical Trials* Care Coaching / Consultation Information / Education / Driving Evaluation* Early Stage Support Groups* Engagement Programs (arts, social, creativity)* Exercise / Nutrition / Cognitive Habilitation* Home Care / Companion Services* Assisted Living Medic Alert Safe Return ® * limited availability

65

66 Middle Stage Current Services in Minnesota Medical Evaluation / Diagnosis / Pharmacological Treatment Research / Clinical Trials* Care Coaching / Consultation / Counseling Information / Education / Driving Evaluation* Caregiver Support Groups* Adult Day Services* Meals on Wheels* Home Care / Home Health Care / Respite Services* Medic Alert Safe Return ® Assisted Living / Nursing Facility * limited availability

67 Late Stage Current Services in Minnesota Medical Evaluation / Diagnosis / Pharmacological Treatment Care Coaching / Consultation / Counseling Information / Education Caregiver Support Groups* Adult Day Services* Meals on Wheels* Home Care / Home Health Care / Respite Services* Medic Alert Safe Return ® Assisted Living / Nursing Facility Hospice* * limited availability

68 Research Minnesota Resources Alzheimer’s Disease Research Center – Mayo Clinic University of Minnesota VA Medical Center Alzheimer’s Research Center, Regions Hospital Health Partners Research Fund Healthcare Interactive (HCI) TrialMatch: ls_trialmatch.asp

69 ACL Projects Minnesota Resources Family Memory Care: evidence-based consultation Systems Integration: dementia capability Telephone / Internet Resources Alzheimer’s Association alz.org Senior LinkAge Line® MinnesotaHelp.info®

AD: The Patient Experience 70

Conclusion / Q&A 71